In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Related Posts
AI and Digital Technology in Regulatory Submissions
Credit: Tierney | stock.adobe.com The pharmaceutical industry is making significant strides driven by digital innovation and artificial intelligence (AI). As…
Future Use of Artificial Intelligence in Clinical Trials
ACT: Looking forward, where do you see the use of artificial intelligence (AI) in clinical trials in five years? Lacroix:…
DIA’s Objectives for the Remainder of 2024
ACT: What are your goals or objectives for DIA for the remainder of the year? Pierce: There are so many…